Format

Send to

Choose Destination
J BUON. 2019 Jan-Feb;24(1):407.

Trastuzumab-emtansine might affect the survival outcome by reversing increased platelet-to-lymphocyte ratio in HER2-positive metastatic breast cancer patients.

Author information

1
MKA Breast Cancer Clinic, Tepe Prime, Cankaya, Ankara, Turkey.
PMID:
30942001

Supplemental Content

Loading ...
Support Center